SIGA Announces Priority Review Voucher Transaction Totaling $80 Million Read more about SIGA Announces Priority Review Voucher Transaction Totaling $80 Million SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox Read more about SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018 Read more about SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018 SIGA Technologies to Host Business Update Webcast on September 27, 2018 Read more about SIGA Technologies to Host Business Update Webcast on September 27, 2018 SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018 Read more about SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018 SIGA Technologies Awarded BARDA Contract for TPOXX® Read more about SIGA Technologies Awarded BARDA Contract for TPOXX® U.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox Read more about U.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine Read more about Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018 Read more about SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018 SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX® Read more about SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX® Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last » Subscribe to
SIGA Announces Priority Review Voucher Transaction Totaling $80 Million Read more about SIGA Announces Priority Review Voucher Transaction Totaling $80 Million
SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox Read more about SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018 Read more about SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018
SIGA Technologies to Host Business Update Webcast on September 27, 2018 Read more about SIGA Technologies to Host Business Update Webcast on September 27, 2018
SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018 Read more about SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018
SIGA Technologies Awarded BARDA Contract for TPOXX® Read more about SIGA Technologies Awarded BARDA Contract for TPOXX®
U.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox Read more about U.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox
Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine Read more about Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine
SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018 Read more about SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018
SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX® Read more about SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®